Bachem Holding AG (0QND.L)
CHF 63.8
(-0.47%)
CHF 63.8
(-0.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 362.35 Million CHF | 69.16% |
| 2022 | 214.2 Million CHF | 20.68% |
| 2021 | 177.49 Million CHF | -24.52% |
| 2020 | 235.17 Million CHF | 17.98% |
| 2019 | 199.32 Million CHF | -13.52% |
| 2018 | 230.48 Million CHF | 35.2% |
| 2017 | 170.48 Million CHF | 30.0% |
| 2016 | 131.14 Million CHF | 44.96% |
| 2015 | 90.46 Million CHF | 5.34% |
| 2014 | 85.88 Million CHF | -16.08% |
| 2013 | 102.33 Million CHF | -20.35% |
| 2012 | 128.48 Million CHF | 1.92% |
| 2011 | 126.06 Million CHF | 26.56% |
| 2010 | 99.6 Million CHF | 1.3% |
| 2009 | 98.32 Million CHF | 19.67% |
| 2008 | 82.16 Million CHF | 17.9% |
| 2007 | 69.69 Million CHF | 31.44% |
| 2006 | 53.02 Million CHF | 39.59% |
| 2005 | 37.98 Million CHF | 0.22% |
| 2004 | 37.9 Million CHF | 18.82% |
| 2003 | 31.89 Million CHF | -4.01% |
| 2002 | 33.22 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 415.04 Million CHF | 0.0% |
| 2023 FY | 362.35 Million CHF | 69.16% |
| 2023 Q4 | 362.35 Million CHF | 0.0% |
| 2023 Q2 | 250.76 Million CHF | 0.0% |
| 2022 FY | 214.2 Million CHF | 20.68% |
| 2022 Q4 | 214.2 Million CHF | 0.0% |
| 2022 Q2 | 149.18 Million CHF | 0.0% |
| 2021 Q2 | 281.17 Million CHF | 0.0% |
| 2021 Q4 | 177.49 Million CHF | 0.0% |
| 2021 FY | 177.49 Million CHF | -24.52% |
| 2020 Q4 | 235.17 Million CHF | 0.0% |
| 2020 Q2 | 226.89 Million CHF | 0.0% |
| 2020 FY | 235.17 Million CHF | 17.98% |
| 2019 Q2 | 186.32 Million CHF | 0.0% |
| 2019 Q4 | 199.32 Million CHF | 0.0% |
| 2019 FY | 199.32 Million CHF | -13.52% |
| 2018 Q4 | 230.48 Million CHF | 0.0% |
| 2018 Q2 | 219.42 Million CHF | 0.0% |
| 2018 FY | 230.48 Million CHF | 35.2% |
| 2017 FY | 170.48 Million CHF | 30.0% |
| 2017 Q4 | 170.48 Million CHF | 0.0% |
| 2017 Q2 | 159.97 Million CHF | 0.0% |
| 2016 FY | 131.14 Million CHF | 44.96% |
| 2016 Q4 | 131.14 Million CHF | 0.0% |
| 2016 Q2 | 108.19 Million CHF | 0.0% |
| 2015 Q4 | 90.46 Million CHF | 0.0% |
| 2015 FY | 90.46 Million CHF | 5.34% |
| 2015 Q2 | 89.31 Million CHF | 0.0% |
| 2014 Q2 | 89.09 Million CHF | 0.0% |
| 2014 Q4 | 85.88 Million CHF | 0.0% |
| 2014 FY | 85.88 Million CHF | -16.08% |
| 2013 Q2 | 108.47 Million CHF | 0.0% |
| 2013 FY | 102.33 Million CHF | -20.35% |
| 2013 Q4 | 102.33 Million CHF | 0.0% |
| 2012 FY | 128.48 Million CHF | 1.92% |
| 2012 Q2 | 133.54 Million CHF | 0.0% |
| 2012 Q4 | 128.48 Million CHF | 0.0% |
| 2011 Q2 | 127.6 Million CHF | 0.0% |
| 2011 Q4 | 126.06 Million CHF | 0.0% |
| 2011 FY | 126.06 Million CHF | 26.56% |
| 2010 Q2 | 106.82 Million CHF | 0.0% |
| 2010 FY | 99.6 Million CHF | 1.3% |
| 2010 Q4 | 99.6 Million CHF | 0.0% |
| 2009 Q4 | 98.32 Million CHF | 0.0% |
| 2009 FY | 98.32 Million CHF | 19.67% |
| 2008 FY | 82.16 Million CHF | 17.9% |
| 2007 FY | 69.69 Million CHF | 31.44% |
| 2006 FY | 53.02 Million CHF | 39.59% |
| 2005 FY | 37.98 Million CHF | 0.22% |
| 2004 FY | 37.9 Million CHF | 18.82% |
| 2003 FY | 31.89 Million CHF | -4.01% |
| 2002 FY | 33.22 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Relief Therapeutics Holding AG | 24.16 Million CHF | -1399.698% |
| Tecan Group AG | 725.05 Million CHF | 50.024% |
| Santhera Pharmaceuticals Holding AG | 49.68 Million CHF | -629.294% |
| Basilea Pharmaceutica AG | 183.29 Million CHF | -97.694% |
| Siegfried Holding AG | 1.02 Billion CHF | 64.592% |
| Molecular Partners AG | 21.92 Million CHF | -1552.862% |